Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
AI Sentiment
Highly Positive
8/10
as of 12-12-2025 3:36pm EST
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
| Founded: | 2018 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 35.3M | IPO Year: | 2021 |
| Target Price: | $2.00 | AVG Volume (30 days): | 128.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.40 - $1.65 | Next Earning Date: | 10-01-2025 |
| Revenue: | $289,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 2582.74% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
IINN Breaking Stock News: Dive into IINN Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
8/10
See how IINN stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "IINN Inspira Technologies Oxy B.H.N. Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.